According to the results of our analysis of GSE13507, the expression of CD163 in primary BLCA tumors and recurrent tumors was positively correlated with the expression of ESR1 and was statistically significant (Sfig.1D). This evidence concerns the gene CD163 and bladder transitional cell carcinoma.